ARS Pharmaceuticals, Inc. (SPRY) Institutional Ownership

Ownership Summary

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) currently has 188 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of ARS Pharmaceuticals owned by institutions changed from 83.8% in June 2025 to 84.7% in September 2025, marking a slight up trend.
• The company experienced a 14.21% quarterly change in institutional shares held, alongside an increase of 27.03% in total owners annually.
• During the quarter, 104 institutions bought more ARS Pharmaceuticals shares, 51 sold shares, and 33 of the 188 total investors held their position steady.
• The aggregate institutional position in ARS Pharmaceuticals now stands at 83.73Mn shares as of September 2025, after investors increased their holdings (up by 10.42Mn shares quarter on quarter which is up 19.76Mn shares year over year).
• RA CAPITAL MANAGEMENT, L.P. continues to be the largest institutional holder of ARS Pharmaceuticals as of September 30, 2025, with a position of 10.86Mn shares, representing 10.99% of the company's outstanding stock.
• Among the most significant buyers of ARS Pharmaceuticals during September 2025 were Rubric Capital Management LP (3.21Mn), Casdin Capital, LLC (1.60Mn), Aberdeen Group plc (1.59Mn), BAMCO INC /NY/ (1.23Mn), Eversept Partners, LP (927.72K).
• Leading sellers of ARS Pharmaceuticals stock in September 2025 included DEERFIELD MANAGEMENT COMPANY, L.P. (2.22Mn), ALLIANCEBERNSTEIN L.P. (1.18Mn), FMR LLC (824.50K), PERCEPTIVE ADVISORS LLC (667.32K), BARCLAYS PLC (393.67K).
• The top 10 institutional holders of ARS Pharmaceuticals for the quarter ending September 2025 included RA CAPITAL MANAGEMENT, L.P. (10.86Mn), ORBIMED ADVISORS LLC (8.29Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (7.50Mn), BlackRock, Inc. (4.83Mn), Rubric Capital Management LP (4.50Mn), SR ONE CAPITAL MANAGEMENT, LP (4.01Mn), VANGUARD GROUP INC (3.50Mn), Aberdeen Group plc (3.10Mn), STATE STREET CORP (2.90Mn), ALLIANCEBERNSTEIN L.P. (2.64Mn).